The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial
Titel:
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial
Auteur:
Zhu, Yajing Zerdes, Ioannis Matikas, Alexios Cruz, Ivette Raices Bergqvist, Mattias Elinder, Ellinor Bosch, Ana Lindman, Henrik Einbeigi, Zakaria Andersson, Anne Carlsson, Lena Dreifaldt, Ann Charlotte Isaksson-Friman, Erika Hellstrom, Mats Johansson, Hemming Wang, Kang Bergh, Jonas C. S. Hatschek, Thomas Foukakis, Theodoros